Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Proteomic landscape of primary and metastatic brain tumors for heterogeneity discovery.

Proteomics. Clinical applications - 1 Mar 2024

Yang Shuang, Zhou Chengbin, Zhang Lei, Xiong Yueting, Zheng Yongtao, Bian Liuguan, Liu Xiaohui

Abstract excerpt

PURPOSE: Despite recent advancements in our understanding of driver gene mutations and heterogeneity within brain tumors, whether primary or metastatic (also known as secondary), our comprehension of proteomic changes remains inadequate. The aim of this study is to provide an informative source for brain tumor researches, and distinguish primary brain tumors and secondary brain tumors from extracranial origins...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to IDH1 gene
Share to Glioma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mass Spectrometry

Share to Mutation

Share to Proteomics

Source

Identifiers

PMID: 37726528
DOI: 10.1002/prca.202300010

Genes

IDH1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Proteomic landscape of primary and metastatic brain tumors for heterogeneity discovery.PMID 37726528Read ↗

Proteomic landscape of primary and metastatic brain tumors for heterogeneity discoverySemantic proximity Read ↗

Proteomic landscape of primary and metastatic brain tumors for heterogeneity discoverySemantic proximity Read ↗

Proteomics separates adult-type diffuse high-grade gliomas in metabolic subgroups independent of 1p/19q codeletion and across IDH mutational status.Semantic proximity Read ↗

Multi-pronged proteomic analysis to study the glioma pathobiology using cerebrospinal fluid samples.Semantic proximity Read ↗

Glioma Pathophysiology: Insights Emerging from ProteomicsSemantic proximity Read ↗

Integrated proteomic analysis of low-grade gliomas reveals contributions of 1p-19q co-deletion to oligodendroglioma.Semantic proximity Read ↗

Defining Protein Pattern Differences Among Molecular Subtypes of Diffuse Gliomas Using Mass Spectrometry*[S]Semantic proximity Read ↗

Heterogenous Profiles Between Matched Primary Tumors and Brain Metastases Reveal Tumor EvolutionSemantic proximity Read ↗

A large-scale targeted proteomics of serum and tissue shows the utility of classifying high grade and low grade meningioma tumorsSemantic proximity Read ↗

Spatial analysis of the glioblastoma proteome reveals specific molecular signatures and markers of survivalSemantic proximity Read ↗

IDH-mutant gliomas with additional class-defining molecular events.Semantic proximity Read ↗

Proteogenomic and metabolomic characterization of human glioblastoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.